Ultradeep Sequencing Study of Chronic Hepatitis C Virus Genotype 1 Infection in Patients Treated with Daclatasvir, Peginterferon, and Ribavirin

Direct-acting antivirals (DAAs) are either part of the current standard of care or are in advanced clinical development for the treatment of patients chronically infected with hepatitis C virus (HCV) genotype 1, but concern exists with respect to the patients who fail these regimens with emergent dr...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Murakami, Eisuke, Imamura, Michio, Hayes, C. Nelson, Abe, Hiromi, Hiraga, Nobuhiko, Honda, Yoji, Ono, Atsushi, Kosaka, Keiichi, Kawaoka, Tomokazu, Tsuge, Masataka, Aikata, Hiroshi, Takahashi, Shoichi, Miki, Daiki, Ochi, Hidenori, Matsui, Hirotaka, Kanai, Akinori, Inaba, Toshiya, McPhee, Fiona, Chayama, Kazuaki
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 2014
Предметы:
Antiviral Agents
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4023772/
https://ncbi.nlm.nih.gov/pubmed/24468783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02068-13
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы